Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2017-08-01 | 2018-02-21 | 17853 |
| TEVA-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-04-05 | 2024-07-03 | 224451 |
| TEVA-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2019-08-22 | 2019-11-07 | 92166 |
| TEVA-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2025-05-15 | 2025-07-18 | 257516 |
| TEVA-ATOMOXETINE | 18MG | CAPSULE | Resolved | 2020-04-02 | 2021-04-15 | 110670 |
| TEVA-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2017-11-16 | 2018-02-21 | 29447 |
| TEVA-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2025-09-25 | 2025-12-18 | 267874 |
| TEVA-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-03-26 | 2021-04-15 | 109632 |
| TEVA-ATOMOXETINE | 10MG | CAPSULE | Actual shortage | 2025-09-18 | 2025-10-02 | 267460 |
| TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2023-11-09 | 2023-12-14 | 209669 |
| TEVA-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2025-08-08 | 2025-08-29 | 264807 |
| TEVA-ATOMOXETINE | 18MG | CAPSULE | Resolved | 2025-08-08 | 2025-09-18 | 264804 |
| TEVA-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2020-04-10 | 2021-04-15 | 111862 |
| TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2022-08-18 | 2022-10-01 | 167188 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177517 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2020-04-10 | 2020-04-16 | 111816 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2025-06-05 | 2025-07-03 | 259701 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2025-01-30 | 2025-03-20 | 249204 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-02-05 | 2021-03-11 | 133448 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2020-04-16 | 2020-04-23 | 112367 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258565 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258616 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258619 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260534 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258577 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258768 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258783 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258496 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258484 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258490 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |